ArticleFrontiers in neurology
Neuronal exosomal miR-25-3p attenuates M1 microglial activation and neurotoxicity by targeting TLR4 to regulate the NF-κB signaling pathway.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Perioperative neurocognitive disorders (PND) are severe postoperative complications in the elderly, with neuroinflammation driven by pro-inflammatory M1 microglia being a core pathological mechanism. This study aimed to investigate the role of neuron-derived exosomes in regulating microglial polarization and its underlying molecular mechanism. Methods: We utilized a neuron-microglia transwell co-culture system. By modulating microRNA-25-3p (miR-25-3p) in neurons or Toll-like receptor 4 (TLR4) in microglia, we assessed microglial M1/M2 polarization, TLR4/NF-κB pathway activation, and subsequent neurotoxicity using qRT-PCR, Western Blot, flow cytometry, and dual-luciferase reporter assays. Results: Neuronal exosomes were effectively internalized by microglia. Exosomal miR-25-3p suppressed the activation of the TLR4/MyD88/NF-κB signaling pathway by directly targeting the 3'-UTR of TLR4. This significantly inhibited microglial polarization towards the pro-inflammatory M1 phenotype and reduced the release of pro-inflammatory cytokines. Functionally, this process attenuated M1 microglia-mediated neuronal apoptosis, oxidative stress, and functional impairment. Direct manipulation of TLR4 expression in microglia confirmed its pivotal role in this regulatory axis. Conclusion: Our findings systematically demonstrate that neurons can release exosomes carrying miR-25-3p to target and suppress the microglial TLR4/NF-κB signaling pathway, thereby inhibiting M1 polarization and alleviating neurotoxicity. This discovery deepens the understanding of PND pathophysiology and provides a theoretical basis and potential therapeutic targets for novel PND treatment strategies targeting neuron-glia communication.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.